Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 637

1.

Canadian Cardiovascular Society atrial fibrillation guidelines 2010: rate and rhythm management.

Gillis AM, Verma A, Talajic M, Nattel S, Dorian P; CCS Atrial Fibrillation Guidelines Committee.

Can J Cardiol. 2011 Jan-Feb;27(1):47-59. doi: 10.1016/j.cjca.2010.11.001. Erratum in: Can J Cardiol. 2011 May-Jun;27(3):388.

PMID:
21329862
2.

Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.

Naccarelli GV, Wolbrette DL, Khan M, Bhatta L, Hynes J, Samii S, Luck J.

Am J Cardiol. 2003 Mar 20;91(6A):15D-26D. Review.

PMID:
12670638
3.

Atrial fibrillation: rate control often better than rhythm control.

[No authors listed]

Prescrire Int. 2004 Apr;13(70):64-9.

PMID:
15148984
4.

Pharmacologic management of atrial fibrillation: current therapeutic strategies.

Lévy S.

Am Heart J. 2001 Feb;141(2 Suppl):S15-21. Review.

PMID:
11174354
5.

Dronedarone for the treatment of atrial fibrillation and atrial flutter.

Maund E, McKenna C, Sarowar M, Fox D, Stevenson M, Pepper C, Palmer S, Woolacott N.

Health Technol Assess. 2010 Oct;14(Suppl. 2):55-62. doi: 10.3310/hta14suppl2/08. Review.

6.

Current management of symptomatic atrial fibrillation.

Haghi D, Schumacher B.

Am J Cardiovasc Drugs. 2001;1(2):127-39. Review.

PMID:
14728042
7.

Rhythm- and rate-controlling effects of dronedarone in patients with atrial fibrillation (from the ATHENA trial).

Page RL, Connolly SJ, Crijns HJ, van Eickels M, Gaudin C, Torp-Pedersen C, Hohnloser SH; ATHENA Investigators.

Am J Cardiol. 2011 Apr 1;107(7):1019-22. doi: 10.1016/j.amjcard.2010.11.028. Epub 2011 Feb 4.

PMID:
21296333
9.
10.

Antiarrhythmic agents for atrial fibrillation: focus on prolonging atrial repolarization.

Singh BN, Mody FV, Lopez B, Sarma JS.

Am J Cardiol. 1999 Nov 4;84(9A):161R-173R. Review.

PMID:
10568677
11.

Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation.

Freemantle N, Lafuente-Lafuente C, Mitchell S, Eckert L, Reynolds M.

Europace. 2011 Mar;13(3):329-45. doi: 10.1093/europace/euq450. Epub 2011 Jan 11.

12.

An evaluation of the strategy of maintenance of sinus rhythm by antiarrhythmic drug therapy after ablation and pacing therapy in patients with paroxysmal atrial fibrillation.

Brignole M, Menozzi C, Gasparini M, Bongiorni MG, Botto GL, Ometto R, Alboni P, Bruna C, Vincenti A, Verlato R; PAF 2 Study Investigators.

Eur Heart J. 2002 Jun;23(11):892-900.

PMID:
12042011
13.

Atrial fibrillation: drug therapies for ventricular rate control and restoration of sinus rhythm.

Chandramouli BV, Kotler MN.

Geriatrics. 1998 Jun;53(6):46-8, 51-2, 54, 57-60. Review.

PMID:
9634106
14.

Dronedarone: a promising alternative for the management of atrial fibrillation.

Yalta K, Turgut OO, Yilmaz MB, Yilmaz A, Tandogan I.

Cardiovasc Drugs Ther. 2009 Oct;23(5):385-93. doi: 10.1007/s10557-009-6189-0. Review.

PMID:
19669399
15.

Atrial fibrillation and atrial flutter.

Geraets DR, Kienzle MG.

Clin Pharm. 1993 Oct;12(10):721-35; quiz 783-4. Review.

PMID:
7903069
16.

Arrhythmias in the intensive care patient.

Trappe HJ, Brandts B, Weismueller P.

Curr Opin Crit Care. 2003 Oct;9(5):345-55. Review.

PMID:
14508146
17.
18.

Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.

Bollmann A, Husser D, Cannom DS.

Am J Cardiovasc Drugs. 2005;5(6):371-8. Review.

PMID:
16259525
19.

Systematic electrocardioversion for atrial fibrillation and role of antiarrhythmic drugs: a substudy of the SAFE-T trial.

Singh SN, Tang XC, Reda D, Singh BN.

Heart Rhythm. 2009 Feb;6(2):152-5. doi: 10.1016/j.hrthm.2008.10.036. Epub 2008 Oct 29.

PMID:
19187902
20.

The Atrial Fibrillation Follow-up Investigation of Rhythm Management (AFFIRM) study: approaches to control rate in atrial fibrillation.

Olshansky B, Rosenfeld LE, Warner AL, Solomon AJ, O'Neill G, Sharma A, Platia E, Feld GK, Akiyama T, Brodsky MA, Greene HL; AFFIRM Investigators.

J Am Coll Cardiol. 2004 Apr 7;43(7):1201-8.

Items per page

Supplemental Content

Write to the Help Desk